head and neck roundtable asco 2016 the immune system and pd-1 inhibitors
Published 8 years ago • 168 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
4:16
head and neck roundtable asco 2016 common side effects of pd-1 inhibitors
-
4:36
asco 2016 – treating head and neck cancer – immunotherapy as first-line treatment, combinations
-
4:06
head and neck roundtable asco 2016 are there less toxic alternatives to the extreme regimen
-
2:04
asco 2016 – treating head and neck cancer – using biomarkers in immunotherapy
-
1:55
asco 2016 – treating head and neck cancer – promising early data for the oral inhibitor buparlisib
-
9:16
asco 2018 head and neck roundtable advances in immunotherapy in head and neck cancer
-
3:46
immunotherapy treatments in patients with head and neck cancer - asco recaps head and neck cancer
-
4:17
asco 2016 – treating head/ neck cancer – keynote 55: pembrolizumab for heavily pre-treated pts
-
3:30
combination therapy for head and neck cancer - asco recaps head and neck cancer patient education
-
2:58
how promising are the results from checkmate 141?
-
3:35
recurrent or metastatic head and neck cancer - asco recaps head and neck cancer patient education
-
9:02
asco/esmo 2020 - the future of head and neck cancer treatment
-
26:30
head and neck cancer treatment update: pembrolizumab, nivolumab and pd-l1 markers
-
10:08
asco/esmo 2020 - head and neck cancer updates - javelin100 trial update
-
13:45
curative modalities & immunotherapy for head & neck cancer - 2021 asco esmo head & neck recap
-
11:07
palliative care and studies for incurable head and neck cancers - 2021 asco esmo head & neck recap
-
5:15
emerging treatment options for head and neck cancer - hpv advances